The long-term effect of generic price competition on the Hungarian statin market

BACKGROUND: Generic competition is a vital health policy tool used in regulating the pharmaceutical market. Drug group HMG-CoA reductase (3-hydroxy-3-methyl-glutaryl-coenzyme-A reductase) inhibitors, widely known as “statins,” was the first drug group in Hungary in which generic prescriptions became...

Descripción completa

Detalles Bibliográficos
Autores principales: Répásy, Balázs, Gazsó, Tibor, Elmer, Diána, Pónusz-Kovács, Dalma, Kajos, Fanni Luca, Csákvári, Tímea, Kovács, Bettina, Boncz, Imre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163807/
https://www.ncbi.nlm.nih.gov/pubmed/37147682
http://dx.doi.org/10.1186/s12913-023-09431-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163807/
https://www.ncbi.nlm.nih.gov/pubmed/37147682
http://dx.doi.org/10.1186/s12913-023-09431-6

Ejemplares similares